protein
therapeut
fastestgrow
class
us
food
drug
administr
fda
approv
drug
treat
difficulttomanag
human
diseas
cancer
diabet
cardiovascular
neurolog
disord
howev
current
regimen
mainli
restrict
extracellular
target
due
inabl
protein
enter
cell
exosom
natur
nanovesicl
circul
human
bodi
possess
intrins
abil
deliv
variou
protein
cargo
recipi
cell
thu
repres
untap
sourc
effect
deliveri
carrier
toward
intracellular
target
concept
use
exosom
protein
deliveri
attempt
remain
fulli
exploit
exosom
lipid
bilayerenclos
extracellular
vesicl
transport
protein
nucleic
acid
lipid
cell
mammal
exosom
activ
releas
almost
type
cell
exist
bodi
fluid
circul
blood
exosom
recogn
endocytos
tissu
cell
via
specif
interact
surfacemembran
protein
deliv
molecular
cargo
therefor
function
cellcel
commun
play
import
role
immunodefens
pathogen
spread
inflamm
tumor
metastasi
tissu
repair
exosom
design
natur
deliv
larg
specif
cargo
function
biomolecul
featur
guid
develop
exosomebas
vehicl
target
deliveri
therapeut
agent
studi
howev
impact
gap
knowledg
exosom
biogenesi
approach
engin
exosom
molecular
cargo
enhanc
uptak
target
cell
studi
describ
pseudotyp
approach
load
exosom
membran
report
target
protein
pseudotyp
often
use
product
recombin
virus
involv
packag
genet
compon
viru
dna
rna
envelop
protein
deriv
differ
viru
method
allow
one
select
viral
envelop
protein
alter
host
tropism
may
result
enhanc
infect
recombin
viru
g
glycoprotein
vesicular
stomat
viru
glycoprotein
vsvg
frequent
use
viral
pseudotyp
owe
broad
tropism
high
efficaci
transduct
fact
retrovirus
approv
clinic
trial
pseudotyp
vsvg
mechanist
vsvg
incorpor
viral
envelop
bud
microdomain
plasma
membran
domain
involv
format
endosom
exosom
connect
led
us
propos
possibl
engin
exosom
specif
membranebound
protein
express
geneencod
vsvg
fusion
protein
mother
cell
take
advantag
modular
structur
welldefin
membran
topolog
vsvg
engin
vsvg
achiev
follow
two
biolog
object
effect
protein
load
via
termin
tag
vsvg
enhanc
exosom
uptak
via
vsvg
pseudotyp
gener
exosom
harbor
vsvg
fusion
protein
recogn
surfac
biomark
target
cell
possibl
gener
exosom
repurpos
vehicl
intracellular
deliveri
function
fluoresc
protein
antibodi
diseas
cell
highcontrast
imag
therapi
respect
report
first
proof
concept
pseudotyp
approach
load
exosom
membran
cargo
report
protein
design
construct
set
vsvg
fusion
report
valid
abil
exosom
incorpor
live
human
cell
studi
demonstr
success
exosom
target
protein
load
via
transfect
fluoresc
monitor
live
mammalian
cell
domain
swap
subsequ
identifi
minim
molecular
scaffold
vsvg
mvsvg
contain
suffici
signal
exosom
target
protein
load
demonstr
robust
intern
pseudotyp
exosom
varieti
cell
type
includ
four
somat
two
induc
pluripot
stem
ip
cell
line
collect
studi
offer
simpl
effect
approach
engin
exosom
vehicl
enhanc
deliveri
protein
report
protein
therapeut
target
cell
human
embryon
kidney
cell
purchas
alstem
richmond
ca
usa
human
glioblastoma
cell
human
liver
cancer
cell
mous
adipos
tissu
fibroblast
cell
purchas
american
type
cultur
collect
manassa
va
usa
cell
maintain
highglucos
dulbecco
modifi
eagl
medium
supplement
fetal
bovin
serum
mm
glutamax
thermo
fisher
scientif
waltham
usa
uml
penicillinstreptomycin
confluenc
cell
treat
trypsinethylenediaminetetraacet
acid
dissoci
pass
ratio
human
ip
cell
purchas
alstem
line
preadapt
feederfre
condit
maintain
serumfre
medium
stemcel
technolog
vancouv
bc
canada
supplement
uml
penicillinstreptomycin
cell
incub
co
transfect
perform
sixwel
plate
unless
otherwis
state
confluenc
cell
transfect
plasmid
dna
mix
either
lipofectamin
thermo
fisher
scientif
fugen
transfect
reagent
promega
fitchburg
wi
usa
fulllength
vsvg
fvsvg
geneencod
singletransmembran
protein
use
make
variou
fusion
construct
figur
b
fusion
construct
configur
per
follow
constitut
cytomegaloviru
promot
signal
peptid
sp
infram
insert
red
fluoresc
protein
rfp
gaussia
luciferas
gluc
stem
sequenc
transmembran
helix
cytosol
tail
follow
infram
rfp
gfp
gluc
lack
endogen
sp
sequenc
stop
codon
figur
polyadenyl
signal
ad
end
construct
fusion
protein
express
vector
conduct
use
combin
polymeras
chain
reaction
amplif
individu
fragment
subsequ
display
rfp
gluc
outer
surfac
exosom
ectodomain
vsvg
swap
indic
report
protein
load
rfp
gfp
gluc
insid
exosom
sequenc
insert
end
cytoplasm
tail
vsvg
figur
construct
exosom
endosom
marker
previous
report
posit
exosom
tracer
xpackgfp
purchas
system
bioscienc
final
construct
confirm
doublestrand
dna
sequenc
elim
biopharmaceut
hayward
ca
usa
sequenc
fvsvg
fusion
protein
also
provid
supplementari
materi
pseudotyp
subsequ
prepar
exosom
cultur
cell
perform
describ
previous
briefli
cell
grown
cm
plate
confluenc
transfect
fugen
transfect
reagent
hour
transfect
cell
switch
serumfre
ultracultur
medium
lonza
basel
switzerland
product
pseudotyp
exosom
hour
condit
medium
collect
centrifug
g
minut
subject
ultrafiltr
filter
filter
medium
subsequ
mix
exoquicktc
system
bioscienc
follow
centrifug
g
minut
enrich
exosom
pellet
resuspend
phosphat
buffer
store
futur
use
protein
concentr
prepar
exosom
measur
nanodrop
lite
thermo
fisher
scientif
gluc
assay
conduct
previous
report
briefli
condit
medium
collect
centrifug
meyer
et
al
g
minut
typic
experi
condit
medium
contain
modifi
exosom
analyz
gluc
activ
use
synergi
ht
multimod
micropl
reader
biotek
instrument
winooski
vt
usa
data
present
rel
light
unit
comparison
exosom
pulldown
assay
conduct
use
exoflow
kit
system
bioscienc
briefli
streptavidincoupl
magnet
bead
mix
biotinlabel
antibodi
hour
bead
wash
pseudotyp
exosom
incub
overnight
antibodycaptur
bead
exosom
pulldown
bead
wash
extens
transfer
clear
well
plate
prior
imag
bead
without
antibodi
use
neg
control
exosom
isol
transfect
cell
subject
nta
use
machin
malvern
instrument
malvern
uk
typic
analysi
ml
dilut
exosom
dilut
use
exosom
visual
laserlight
scatter
three
video
second
record
data
analysi
perform
nta
softwar
result
present
graphic
show
particl
size
distribut
exosom
uptak
assay
recipi
cell
seed
plate
incub
exosom
indic
experi
briefli
nonstem
cell
confluenc
load
exosom
proteinwel
serumfre
ultracultur
medium
cell
imag
magnif
use
fluoresc
microscopi
leica
microsystem
wetzlar
germani
ip
cell
line
cell
cultur
matrigelco
plate
load
exosom
serumfre
medium
extens
wash
load
ip
cell
imag
magnif
use
evo
fl
autofluoresc
microscop
microscop
imag
paramet
exposur
time
contrast
gain
experi
fluorescenceactiv
cellsort
analysi
cell
sort
quantifi
use
flow
cytometri
accuri
bd
bioscienc
san
jose
ca
usa
follow
transfect
event
record
sampl
use
channel
detect
fluoresc
rfp
fluorescenceactiv
cellsort
data
analyz
cflow
plu
softwar
bd
bioscienc
imag
typic
taken
live
cell
use
fluoresc
microscopi
show
intracellular
local
fluoresc
fusion
protein
fluoresc
phasecontrast
imag
adjust
bright
contrast
overlaid
use
adob
photoshop
cs
whenev
quantit
comparison
imag
data
obtain
use
ident
paramet
exposur
time
contrast
gain
first
develop
strategi
repurpos
exosom
vehicl
vivo
target
deliveri
imag
proteinbas
therapeut
fluoresc
probe
key
success
pseudotyp
approach
control
topolog
vsvg
exosom
membran
hypothes
prefer
topolog
vsvg
exosom
would
one
vsvg
protein
retain
membran
interact
hydrophob
tail
bilay
membran
anchor
strategi
would
posit
ectodomain
fvsvg
outer
surfac
exosom
pseudotyp
figur
moreov
fuse
target
molecul
fvsvg
one
could
maxim
interact
exosom
surfac
antigen
plasma
membran
target
cell
altern
swap
ectodomain
celltroph
peptid
diseasetarget
antibodi
one
could
target
exosom
specif
tissu
tumor
latter
approach
could
refin
vivo
target
therapi
imag
tumor
diseas
tissu
fuse
engin
antibodi
nearinfrar
fluoresc
protein
test
new
approach
construct
sever
fusion
protein
compos
fvsvg
fluoresc
luminesc
report
way
domain
swap
protein
tag
ensur
fusion
protein
properli
anchor
correct
topographi
exosom
membran
sp
sequenc
transmembran
helix
fvsvg
left
intact
fusion
protein
figur
strategi
would
limit
synthesi
vsvg
surfac
rough
er
sp
sequenc
guid
insert
ectodomain
er
lumen
figur
later
section
manuscript
show
strategi
correctli
posit
intern
journal
nanomedicin
submit
manuscript
wwwdovepresscom
dovepress
dovepress
exosom
pseudotyp
enhanc
protein
deliveri
transmembran
helix
vsvg
fusion
protein
membran
cell
ctermin
tail
project
cytoplasm
previou
studi
shown
sp
sequenc
remov
remain
vsvg
molecul
concentr
tetraspaninenrich
microdomain
plasma
membran
exosom
believ
form
domain
two
sequenti
inwardbud
process
first
gener
endosom
second
lead
format
multiplevesicl
bodi
eventu
releas
individu
exosom
extracellular
space
figur
vsvg
introduc
function
fluoresc
protein
presecret
exosom
next
examin
protein
append
vsvg
function
correctli
posit
exosom
membran
first
gener
two
fusion
protein
tag
gfp
rfp
cterminu
vsvg
cultur
cell
transfect
construct
intracellular
local
express
record
day
fluoresc
microscopi
analysi
imag
data
show
accumul
fluoresc
protein
plasma
membran
cell
within
day
transfect
figur
e
membran
local
fluoresc
protein
evid
compar
fluoresc
signal
phase
contrast
merg
imag
figur
f
day
fluoresc
signal
fusion
protein
found
intracellular
region
cell
figur
g
punctat
intracellular
fluoresc
consist
expect
endocyt
structur
figur
h
argu
intracellular
next
conduct
imag
studi
verifi
fluoresc
vsvg
fusion
express
cell
coloc
endocyt
compart
compar
distribut
vsvg
fluoresc
valid
fluoresc
marker
endosom
studi
conduct
cell
cotransfect
fvsvgrfp
red
endosom
marker
green
show
consider
overlap
two
fluoresc
signal
immedi
appar
larg
number
yellow
puncta
overlaid
imag
figur
k
provid
compel
evid
fluoresc
fvsvg
fusion
protein
local
endosom
next
conduct
studi
show
fluoresc
endosom
vesicl
compon
exosom
biogenesi
pathway
cotransfect
cell
fvsvgrfp
red
green
valid
marker
exosom
highresolut
fluoresc
imag
cell
transfect
two
construct
also
reveal
extens
overlap
green
red
fluoresc
signal
appreci
merg
imag
highlight
overlap
signal
yellow
figur
result
confirm
expect
fvsvg
particip
biogenesi
endocyt
compart
presecret
exosom
togeth
result
imag
studi
consist
hypothesi
fvsvg
serv
molecular
scaffold
integr
correctli
project
append
protein
includ
rfp
exosom
membran
readili
detect
fluoresc
rfp
suggest
protein
payload
fvsvg
function
protein
integr
exosom
membran
highli
effici
identif
minim
vsvg
scaffold
exosom
target
fvsvg
singl
transmembran
glycoprotein
character
spike
protrud
outer
face
viral
particl
present
studi
fvsvg
shown
integr
exosom
membran
ectodomain
project
extern
face
ectodomain
fvsvg
recogn
specif
protein
surfac
recipi
cell
facilit
attach
intern
ask
whether
mvsvg
construct
lack
ectodomain
suffici
anchor
protein
exosom
membran
studi
ectodomain
replac
rfp
although
fusion
protein
contain
ntermin
sp
ctermin
domain
figur
record
imag
red
fluoresc
rfpmvsvg
transfect
cell
red
fluoresc
local
type
puncta
found
mvsvg
fusion
protein
identifi
potenti
endocyt
compart
figur
g
importantli
found
extens
overlap
red
green
fluoresc
signal
cell
cotransfect
rfpmvsvg
fluoresc
fusion
protein
fvsvggfp
figur
c
endosom
marker
figur
f
exosom
marker
figur
figur
strongli
suggest
endosomeexosom
particip
data
identifi
sp
domain
cterminu
vsvg
minim
scaffold
vsvg
exosom
target
next
examin
vsvg
incorpor
exosom
cell
record
kinet
fvsvg
xpack
exosometrac
particip
exosom
transfect
cell
fluoresc
rfpfvsvg
xpackgfp
record
function
time
live
cell
imag
studi
conform
initi
find
earli
appear
rfp
plasma
membran
figur
upper
panel
day
late
particip
fvsvgrfp
intracellular
granul
tent
assign
exosom
figur
upper
panel
day
analysi
correspond
imag
xpackgfp
show
similar
tempor
pattern
figur
lower
panel
would
suggest
fvsvg
xpack
share
common
pathway
exosom
biogenesi
cotransfect
analysi
fluoresc
imag
two
independ
fluoresc
tracer
reveal
extens
coloc
figur
indic
share
similar
intracellular
distribut
cell
find
support
hypothesi
vsvg
preferenti
recruit
exosom
via
endocyt
pathway
explor
whether
incorpor
vsvg
exosom
gener
phenomenon
transfect
vsvgreport
protein
three
addit
cell
line
distribut
fvsvgrfp
record
dynam
type
live
cell
use
fluoresc
microscopi
studi
show
fvsvg
fusion
protein
local
punctat
structur
three
cell
type
strongli
suggest
fvsvg
play
common
role
exosom
biogenesi
varieti
human
cell
type
figur
moreov
found
intracellular
pattern
rfpmvsvg
similar
fvsvg
addit
cell
line
figur
togeth
data
show
fvsvg
mvsvg
capabl
target
introduc
next
ask
vsvgpseudotyp
exosom
releas
produc
cell
extracellular
space
first
construct
two
addit
vsvg
report
mvsvg
fvsvg
fusion
highli
luminesc
luciferas
gaussia
princep
figur
pseudotyp
exosom
releas
transfect
cell
high
level
luciferas
activ
could
expect
condit
medium
predict
detect
high
level
luciferas
condit
medium
higher
glucmvsvg
fvsvggluc
respect
compar
untransfect
control
figur
differ
activ
transfect
luciferas
fusion
protein
two
report
could
aris
limit
avail
coelenterazin
substrat
sinc
glucmvsvg
outer
surfac
exosom
henc
access
substrat
nevertheless
result
suggest
fvsvgmvsvg
carri
append
luciferas
onto
exosom
activ
form
case
exosom
releas
extracellular
space
next
provid
confirm
vsvgpseudotyp
vesicl
produc
cell
true
exosom
studi
exosom
pull
suspens
use
exosom
marker
antibodi
sinc
immunoprecipit
complex
pulldown
emit
strong
gfp
fluoresc
quit
certain
contain
fvsvggfp
presenc
confirm
exosom
figur
next
ask
differenti
pseudotyp
exosom
affect
physic
properti
particular
nta
suspens
exosom
assess
use
averag
diamet
pseudotyp
exosom
integr
fvsvgrfp
rfpmvsvg
similar
figur
e
differ
significantli
averag
size
determin
act
control
particl
studi
figur
g
next
studi
uptak
vsvgpseudotyp
exosom
recipi
cell
key
question
whether
ectodomain
vsvg
may
modul
bind
uptak
exosom
set
studi
compar
bind
uptak
exosom
pseudotyp
fvsvg
versu
mvsvg
deliveri
two
class
engin
exosom
target
cell
determin
imag
distribut
intracellular
red
fluoresc
cell
incub
rfplabel
exosom
cell
incub
purifi
exosom
hour
imag
use
fluoresc
microscopi
approxim
cell
show
strong
perinuclear
fluoresc
due
uptak
rfpfvsvgload
exosom
figur
c
e
g
hand
weak
red
fluoresc
record
incub
cell
type
mvsvgmodifi
exosom
figur
f
h
result
led
two
import
conclus
first
exosom
deliveri
recipi
cell
enhanc
fvsvg
pseudotyp
second
ectodomain
fvsvg
play
import
role
bind
subsequ
uptak
exosom
recipi
cell
encourag
observ
describ
examin
exosom
uptak
complex
cell
type
includ
human
ip
cell
notori
difficult
transfect
use
standard
transfect
protocol
fluoresc
imag
ip
cell
incub
fix
number
fvsvgrfppseudotyp
exosom
hour
show
strong
intracellular
fluoresc
cell
figur
k
notabl
highest
level
exosom
uptak
found
cell
peripheri
stem
cell
coloni
suggest
note
uptak
pseudotyp
exosom
variou
cell
line
compar
fvsvg
mvsvg
cultur
cell
treat
either
fvsvgrfp
rfpmvsvg
plate
enhanc
uptak
fvsvg
evid
ac
gk
compar
mvsvg
df
hl
follow
exosom
incub
hour
imag
taken
fluoresc
microscopi
magnif
cell
scale
bar
cell
imag
taken
exosom
incub
hour
magnif
scale
bar
arrow
point
intern
rfplabel
exosom
abbrevi
vsvg
vesicular
stomat
viru
glycoprotein
fvsvg
fulllength
vsvg
mvsvg
minim
vsvg
metabol
statu
highli
prolifer
cell
may
influenc
exosom
uptak
expect
mvsvgload
exosom
found
taken
low
level
ip
cell
confirm
earlier
find
pseudotyp
ectodomain
domain
critic
effect
attach
intern
recipi
cell
next
use
fluorescenceactiv
cellsort
analysi
quantifi
uptak
differenti
pseudotyp
exosom
human
cell
studi
compar
uptak
fvsvgrfpversu
rfpmvsvgpseudotyp
exosom
cell
incub
plot
figur
cell
emit
rfp
fluoresc
shift
slightli
higher
number
exosom
type
b
compar
control
figur
howev
subtract
background
fluoresc
signal
measur
neg
control
group
measur
increas
exosom
uptak
fvsvgversu
mvsvgmodifi
exosom
figur
similar
result
obtain
exosom
uptak
cell
figur
robust
increas
record
pseudotyp
fvsvg
versu
mvsvg
figur
togeth
result
demonstr
uptak
exosom
divers
cell
type
enhanc
produc
vsvgpseudotyp
exosom
bear
ectodomain
process
protein
therapeut
find
increas
popular
treatment
health
disord
repres
fastestgrow
class
fdaapprov
biolog
protein
therapeut
howev
direct
toward
extracellular
target
difficult
transport
across
plasma
membran
mammalian
cell
studi
describ
new
pseudotyp
approach
engin
exosom
vehicl
intracellular
deliveri
protein
cargo
impart
enhanc
intrins
abil
deliv
bioactiv
cargo
recipi
cell
studi
build
wellestablish
principl
underli
vsvg
pseudotyp
use
produc
recombin
virus
murin
retrovirus
enhanc
effici
gene
deliveri
earli
studi
vsvg
viral
structur
protein
coexpress
incorpor
viral
envelop
form
infecti
recombin
virus
rather
exosom
maguir
et
al
use
vsvg
pseudotyp
extracellular
vesicl
found
adenoassoci
viru
coupl
pseudotyp
vesicl
gain
enhanc
abil
gene
deliveri
implic
extracellular
vesicl
viral
infect
later
studi
marsac
et
al
kuat
et
al
use
vsvg
boost
antibodi
product
viral
peptid
includ
sever
acut
respiratori
syndromeassoci
coronaviru
sarscv
protein
hivgag
epitop
case
vsvg
viral
protein
sarscv
protein
hivgag
includ
compon
exosomebas
vaccin
materi
notabl
mangeot
et
al
abl
use
vsvg
alon
produc
vsvginduc
nanovesicl
term
gesicl
protein
transfer
human
cell
avoid
viral
deliveri
total
although
studi
point
possibl
converg
mechan
via
vesicl
pseudotyp
exact
molecular
mechan
final
destin
vsvg
live
mammalian
cell
remain
elus
importantli
whether
vsvg
molecul
intrins
abil
target
exosom
thu
particularli
use
exosom
engin
remain
test
studi
introduc
vsvg
fusion
protein
exosom
membran
effort
repurpos
exosom
live
vehicl
target
deliveri
protein
cargo
recipi
cell
importantli
repurpos
requir
addit
viral
compon
approach
led
success
incorpor
protein
payload
includ
gfp
rfp
luciferas
exosom
vsvgmodifi
exosom
shown
form
effici
host
cell
secret
extracellular
space
physic
properti
natur
exosom
pseudotyp
result
dramat
increas
exosom
uptak
varieti
mammalian
cell
type
includ
human
ip
cell
pseudotyp
exosom
offer
sever
key
advantag
intracellular
deliveri
protein
therapeut
compar
liposom
nanoscal
polym
first
exosom
cellderiv
nanoparticl
diamet
nm
recogn
self
host
present
repertoir
intrins
surfac
protein
allow
gain
access
tissu
tumor
microenviron
circul
host
longer
period
increas
chanc
deliv
therapeut
cargo
deepseat
cell
solid
tumor
second
exosom
capabl
transport
specif
protein
surfac
within
intern
caviti
featur
exploit
studi
load
exosom
varieti
report
protein
includ
gfp
rfp
luciferas
strategi
develop
deliv
exosom
defin
cell
type
simpli
append
vsvg
enzym
could
form
basi
replac
therapi
hereditari
diseas
cellrecogn
peptid
target
engin
therapeut
antibodi
target
specif
suppressor
cytotox
cell
cancer
therapi
third
demonstr
exosom
pseudotyp
vsvg
intern
divers
collect
human
murin
cell
includ
two
human
ip
cell
line
target
subsequ
intern
exosom
recipi
cell
requir
ectodomain
fourth
role
vsvg
ectodomain
protein
load
deliveri
multifacet
nativ
vsvg
ectodomain
dispens
protein
load
thu
delet
ectodomain
make
room
polypeptid
load
exampl
rfp
replac
ectodomain
chimer
protein
load
onto
exosom
ectodomain
serv
import
dock
molecul
exosom
load
potenti
replac
celltrop
peptid
therefor
strategi
use
engin
target
exosom
deliveri
collect
studi
demonstr
feasibl
use
vsvg
pseudotyp
engin
exosom
biocompat
vehicl
enhanc
molecular
function
increas
target
deliveri
protein
therapeut
modul
gene
express
specif
cell
diseas
tissu
serv
deliv
probe
vivo
imag
tumor
intern
journal
nanomedicin
intern
peerreview
journal
focus
applic
nanotechnolog
diagnost
therapeut
drug
deliveri
system
throughout
biomed
field
journal
index
pubm
central
medlin
ca
current
medicin
journal
citat
reportssci
edit
embas
scopu
elsevi
bibliograph
databas
manuscript
manag
system
complet
onlin
includ
quick
fair
peerreview
system
easi
use
visit
http
wwwdovepresscom
testimonialsphp
read
real
quot
publish
author
